These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure. Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist devices as destination therapy: a new look at survival. Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819 [TBL] [Abstract][Full Text] [Related]
5. Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device? Migliore F; Cavalli G; Bottio T; De Franceschi P; Bertaglia E; Gerosa G; Iliceto S ESC Heart Fail; 2018 Jun; 5(3):218-221. PubMed ID: 29377556 [No Abstract] [Full Text] [Related]
6. Circumventing a left ventricular assist device and implantable cardioverter defibrillator interaction: an alternative method of shielding. Guise KD; Franconame F; Chung EH Europace; 2013 Dec; 15(12):1689. PubMed ID: 23608031 [No Abstract] [Full Text] [Related]
7. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Oswald H; Schultz-Wildelau C; Gardiwal A; Lüsebrink U; König T; Meyer A; Duncker D; Pichlmaier MA; Klein G; Strüber M Eur J Heart Fail; 2010 Jun; 12(6):593-9. PubMed ID: 20406799 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation. Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488 [TBL] [Abstract][Full Text] [Related]
9. [Mechanical devices in the treatment of severe heart failure]. Pakarinen S; Lommi J Duodecim; 2005; 121(11):1217-24. PubMed ID: 15999981 [No Abstract] [Full Text] [Related]
10. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place. Gupta A; Subzposh F; Hankins SR; Kutalek SP Tex Heart Inst J; 2015 Apr; 42(2):140-3. PubMed ID: 25873825 [TBL] [Abstract][Full Text] [Related]
12. Use of an automatic internal defibrillator to induce and maintain ventricular fibrillation during left ventricular assist device pump exchange. Levin MA; Anyanwu AC; Eggert CA; Mittnacht AJ J Thorac Cardiovasc Surg; 2014 Mar; 147(3):e17-8. PubMed ID: 24290714 [No Abstract] [Full Text] [Related]
13. Automated implantable cardiac defibrillator and biventricular Thoratec assist device as bridge to transplantation in a patient with sarcoidosis. Ankersmit HJ; Wieselthaler GA; Moser B; Taghavi S; Grimm M; Roth G; Gorlitzer M; Tschernich H; Horvat R; Wolner E J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1198-9. PubMed ID: 11385390 [No Abstract] [Full Text] [Related]
14. No Electromagnetic Interference Occurred in a Patient with a HeartMate II Left Ventricular Assist System and a Subcutaneous Implantable Cardioverter-Defibrillator. Raman AS; Shabari FR; Kar B; Loyalka P; Hariharan R Tex Heart Inst J; 2016 Apr; 43(2):183-5. PubMed ID: 27127441 [TBL] [Abstract][Full Text] [Related]
15. Interactions between a left ventricular assist device and implantable cardioverter-defibrillator. Netzler PC; Vasuki N; Peura JL; Gold MR Pacing Clin Electrophysiol; 2012 Sep; 35(9):e272-3. PubMed ID: 22452670 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304 [TBL] [Abstract][Full Text] [Related]
17. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506 [TBL] [Abstract][Full Text] [Related]
18. Combining nonpharmacologic therapies for advanced heart failure: the Münster experience with the assist device-defibrillator combination. Deng MC; Tjan TD; Asfour B; Gradaus R; Böcker D; Loick HM; Baba HA; Breithardt G; Scheld HH; Borggrefe M; Hammel D Am J Cardiol; 1999 Mar; 83(5B):158D-160D. PubMed ID: 10089859 [TBL] [Abstract][Full Text] [Related]
19. Left thoracotomy and descending aortic anastomosis for HeartWare implantation after previous coronary artery bypass graft and left ventriculotomy. Botta L; Cannata A; Martinelli L Artif Organs; 2015 Mar; 39(3):288-9. PubMed ID: 25788212 [No Abstract] [Full Text] [Related]
20. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. Matthews JC; Betley D; Morady F; Pelosi F J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1107-8. PubMed ID: 17403078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]